MMW - Fortschritte der Medizin

, Volume 158, Issue 7, pp 41–46 | Cite as

Paradigmenwechsel bei den Ernährungsempfehlungen

So steuern Sie das Essverhalten Ihrer Patienten in die richtige Richtung

  • Katharina Lechner
  • Klaus G. ParhoferEmail author

Seit einigen Jahren zeichnet sich ein Paradigmenwechsel in Bezug auf die Ernährungsempfehlungen bei Typ-2-Diabetes ab. Diese betreffen primär ein Aufheben der Cholesterin- und Fettbegrenzung zugunsten einer Fokussierung auf die Fettqualität sowie Veränderungen der empfohlenen Makronährstoff-Zusammensetzung.

Dietary advice for preventing and treating T2DM: A shift of paradigm


Dietary advice prevention and treatment T2DM shift of paradigm 


  1. 1.
    Deutscher Gesundheitsbericht Diabetes 2015,8.Google Scholar
  2. 2.
    Global status report on noncommunicable diseases 2014. Geneva, World Health Organization, 2012.Google Scholar
  3. 3.
    Beagley J, Guariguata L, Weil C, Motala AA. Global estimates of undiagnosed diabetes in adults. Diabetes Research and Clinical Practice.103(2):150–60.Google Scholar
  4. 4.
    Update of mortality attributable to diabetes for the IDF Diabetes Atlas: Estimates for the year 2011. Diabetes Research and Clinical Practice.100(2):277-9.Google Scholar
  5. 5.
    Domingueti CP, Dusse LM, Carvalho MD, de Sousa LP, Gomes KB, Fernandes AP. Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. Journal of diabetes and its complications. 2015 Dec 18.Google Scholar
  6. 6.
  7. 7.
    Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS medicine. 2006 Nov;3(11):e442.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Zhang P, Zhang X, Brown J, Vistisen D, Sicree R, Shaw J, et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Research and Clinical Practice.87(3):293–301.Google Scholar
  9. 9.
    Feinman RD, Pogozelski WK, Astrup A, Bernstein RK, Fine EJ, Westman EC, et al. Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base. Nutrition (Burbank, Los Angeles County, Calif). 2015 Jan;31(1):1–13.CrossRefGoogle Scholar
  10. 10.
    DiNicolantonio JJ. The cardiometabolic consequences of replacing saturated fats with carbohydrates or Omega-6 polyunsaturated fats: Do the dietary guidelines have it wrong? Open heart. 2014;1(1):e000032.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Walker TB, Parker MJ. Lessons from the war on dietary fat. Journal of the American College of Nutrition. 2014;33(4):347–51.CrossRefPubMedGoogle Scholar
  12. 12.
    Bischoff SC. Adipositas im Erwachsenenalter. Aktuel Ernahrungsmed. 2015 // 13.05.2015;40(03):147–78.CrossRefGoogle Scholar
  13. 13.
    Harcombe Z, Baker JS, Cooper SM, Davies B, Sculthorpe N, DiNicolantonio JJ, et al. Evidence from randomised controlled trials did not support the introduction of dietary fat guidelines in 1977 and 1983: a systematic review and meta-analysis. Open heart. 2015;2(1):e000196.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Taubes G. Nutrition. The soft science of dietary fat. Science (New York, NY). 2001 Mar 30;291(5513):2536–45.Google Scholar
  15. 15.
    Mozaffarian D. Saturated fatty acids and type 2 diabetes: more evidence to re-invent dietary guidelines. The lancet Diabetes & endocrinology. 2014 Oct;2(10):770–2.CrossRefGoogle Scholar
  16. 16.
    Hamdy O. Nutrition revolution the end of the high carbohydrates era for diabetes prevention and management. Diabetes Manag 2014;10:103–104Google Scholar
  17. 17.
    Scholl J, Schneider M. Gesundheitspolitik: Gesundheitsförderung und Prävention weiterdenken. Dtsch Arztebl International. 2015 October 30, 2015;112(44):1830.Google Scholar
  18. 18.
    Hu T, Bazzano LA. The low-carbohydrate diet and cardiovascular risk factors: evidence from epidemiologic studies. Nutrition, metabolism, and cardiovascular diseases: NMCD. 2014 Apr;24(4):337–43.PubMedPubMedCentralGoogle Scholar
  19. 19.
    Twig G, Afek A, Derazne E, Tzur D, Cukierman-Yaffe T, Gerstein HC, et al. Diabetes risk among overweight and obese metabolically healthy young adults. Diabetes care. 2014 Nov;37(11):2989–95.CrossRefPubMedGoogle Scholar
  20. 20.
    Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. Jama. 2003 Jan 1;289(1):76–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Lustig RH, Schmidt LA, Brindis CD. Public health: The toxic truth about sugar. Nature. 2012 Feb 2;482(7383):27–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Taubes G. The science of obesity: what do we really know about what makes us fat? An essay by Gary Taubes. BMJ (Clinical research ed). 2013;346:f1050.Google Scholar
  23. 23.
    Livesey G, Taylor R, Livesey H, Liu S. Is there a dose-response relation of dietary glycemic load to risk of type 2 diabetes? Meta-analysis of prospective cohort studies. The American journal of clinical nutrition. 2013 Mar;97(3):584–96.CrossRefPubMedGoogle Scholar
  24. 24.
    DiNicolantonio JJ, Lucan SC, O’Keefe JH. The Evidence for Saturated Fat and for Sugar Related to Coronary Heart Disease. Progress in cardiovascular diseases. 2015 Nov 14.Google Scholar
  25. 25.
    Mozaffarian D. Diverging global trends in heart disease and type 2 diabetes: the role of carbohydrates and saturated fats. The lancet Diabetes & endocrinology. 2015 Aug;3(8):586–8.CrossRefGoogle Scholar
  26. 26.
    Lustig RH, Mulligan K, Noworolski SM, Tai VW, Wen MJ, Erkin-Cakmak A, et al. Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome. Obesity (Silver Spring, Md). 2016 Feb;24(2):453–60.CrossRefGoogle Scholar
  27. 27.
    Elliott SS, Keim NL, Stern JS, Teff K, Havel PJ. Fructose, weight gain, and the insulin resistance syndrome. The American journal of clinical nutrition. 2002 Nov;76(5):911–22.PubMedGoogle Scholar
  28. 28.
    Malik VS, Hu FB. Fructose and Cardiometabolic Health: What the Evidence From Sugar-Sweetened Beverages Tells Us. Journal of the American College of Cardiology. 2015 Oct 6;66(14):1615–24.CrossRefPubMedGoogle Scholar
  29. 29.
    Stanhope KL, Medici V, Bremer AA, Lee V, Lam HD, Nunez MV, et al. A dose-response study of consuming high-fructose corn syrup-sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults. The American journal of clinical nutrition. 2015 Jun;101(6):1144–54.CrossRefPubMedGoogle Scholar
  30. 30.
    Ley SH, Hamdy O, Mohan V, Hu FB. Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet (London, England). 2014 Jun 7;383(9933):1999–2007.CrossRefGoogle Scholar
  31. 31.
    Cox CL, Stanhope KL, Schwarz JM, Graham JL, Hatcher B, Griffen SC, et al. Consumption of fructose-sweetened beverages for 10 weeks reduces net fat oxidation and energy expenditure in overweight/obese men and women. European journal of clinical nutrition. 2012 Feb;66(2):201–8.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Cox CL, Stanhope KL, Schwarz JM, Graham JL, Hatcher B, Griffen SC, et al. Consumption of fructose- but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-glutamyl transferase activity in overweight/obese humans. Nutrition & metabolism. 2012;9(1):68.CrossRefGoogle Scholar
  33. 33.
    Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. The Journal of clinical investigation. 2009 May;119(5):1322–34.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Basaranoglu M, Basaranoglu G, Bugianesi E. Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction. Hepatobiliary surgery and nutrition. 2015 Apr;4(2):109–16.Google Scholar
  35. 35.
    Huang PL. A comprehensive definition for metabolic syndrome. Disease models & mechanisms. 2009 May-Jun;2(5-6):231–7.CrossRefGoogle Scholar
  36. 36.
    Volek JS, Feinman RD. Carbohydrate restriction improves the features of Metabolic Syndrome. Metabolic Syndrome may be defined by the response to carbohydrate restriction. Nutrition & metabolism. 2005;2:31.CrossRefGoogle Scholar
  37. 37.
    Accurso A, Bernstein RK, Dahlqvist A, Draznin B, Feinman RD, Fine EJ, et al. Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal. Nutrition & metabolism. 2008;5:9.CrossRefGoogle Scholar
  38. 38.
    Larsen TM, Dalskov SM, van Baak M, Jebb SA, Papadaki A, Pfeiffer AF, et al. Diets with high or low protein content and glycemic index for weight-loss maintenance. The New England journal of medicine. 2010 Nov 25;363(22):2102–13.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Gardner CD, Kiazand A, Alhassan S, Kim S, Stafford RS, Balise RR, et al. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial. Jama. 2007 Mar 7;297(9):969–77.CrossRefPubMedGoogle Scholar
  40. 40.
    Halton TL, Willett WC, Liu S, Manson JE, Albert CM, Rexrode K, et al. Low-Carbohydrate-Diet Score and the Risk of Coronary Heart Disease in Women. New England Journal of Medicine. 2006;355(19):1991–2002.CrossRefPubMedGoogle Scholar
  41. 41.
    eWestman EC, Vernon MC. Has carbohydrate-restriction been forgotten as a treatment for diabetes mellitus? A perspective on the ACCORD study design. Nutrition & metabolism. 2008;5:10.CrossRefGoogle Scholar
  42. 42.
  43. 43.
    Feinman R. Carbohydrates for people with diabetes is not cautious. Nutrition (Burbank, Los Angeles County, Calif). 2016 1//;32(1):153–4.CrossRefGoogle Scholar
  44. 44.
    Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML, Wassertheil-Smoller S, et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women’s Health Initiative Randomized Controlled Dietary Modification Trial. Jama. 2006 Feb 8;295(6):655–66.CrossRefPubMedGoogle Scholar
  45. 45.
    Noakes TD. The Women’s Health Initiative Randomized Controlled Dietary Modification Trial: an inconvenient finding and the diet-heart hypothesis. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 2013 Nov;103(11):824–5.Google Scholar
  46. 46.
    Chowdhury R, Warnakula S, Kunutsor S, Crowe F, Ward HA, Johnson L, et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Annals of internal medicine. 2014 Mar 18;160(6):398–406.CrossRefPubMedGoogle Scholar
  47. 47.
    de Souza RJ, Mente A, Maroleanu A, Cozma AI, Ha V, Kishibe T, et al. Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies. BMJ (Clinical research ed). 2015;351:h3978.Google Scholar
  48. 48.
    Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. The American journal of clinical nutrition. 2010 Mar;91(3):535–46.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
  50. 50.
    Berger S, Raman G, Vishwanathan R, Jacques PF, Johnson EJ. Dietary cholesterol and cardiovascular disease: a systematic review and meta-analysis. The American journal of clinical nutrition. 2015 Aug;102(2):276–94.CrossRefPubMedGoogle Scholar
  51. 51.
    Mozaffarian D, Ludwig DS. The 2015 US Dietary Guidelines: Lifting the Ban on Total Dietary Fat. Jama. 2015 Jun 23-30;313(24):2421–2.CrossRefPubMedGoogle Scholar
  52. 52.
    Fuller NR, Caterson ID, Sainsbury A, Denyer G, Fong M, Gerofi J, et al. The effect of a high-egg diet on cardiovascular risk factors in people with type 2 diabetes: the Diabetes and Egg (DIABEGG) study-a 3-mo randomized controlled trial. The American journal of clinical nutrition. 2015 Apr;101(4):705–13.CrossRefPubMedGoogle Scholar
  53. 53.
    Evidenzbasierte Leitlinie: „Fettzufuhr und Prävention ausgewählter ernährungsmitbedingter Krankheiten“, 2. Version (2015).Google Scholar
  54. 54.
    Fernando WM, Martins IJ, Goozee KG, Brennan CS, Jayasena V, Martins RN. The role of dietary coconut for the prevention and treatment of Alzheimer’s disease: potential mechanisms of action. The British journal of nutrition. 2015 Jul 14;114(1):1–14.CrossRefPubMedGoogle Scholar
  55. 55.
    Wang L, Bordi PL, Fleming JA, Hill AM, Kris-Etherton PM. Effect of a moderate fat diet with and without avocados on lipoprotein particle number, size and subclasses in overweight and obese adults: a randomized, controlled trial. Journal of the American Heart Association. 2015 Jan;4(1):e001355.CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Wu L, Piotrowski K, Rau T, Waldmann E, Broedl UC, Demmelmair H, et al. Walnut-enriched diet reduces fasting non-HDL-cholesterol and apolipoprotein B in healthy Caucasian subjects: a randomized controlled cross-over clinical trial. Metabolism: clinical and experimental. 2014 Mar;63(3):382–91.CrossRefGoogle Scholar
  57. 57.
    Kris-Etherton PM, Yu-Poth S, Sabate J, Ratcliffe HE, Zhao G, Etherton TD. Nuts and their bioactive constituents: effects on serum lipids and other factors that affect disease risk. The American journal of clinical nutrition. 1999 Sep;70(3 Suppl):504s–11s.PubMedGoogle Scholar
  58. 58.
    Bao Y, Han J, Hu FB, Giovannucci EL, Stampfer MJ, Willett WC, et al. Association of nut consumption with total and cause-specific mortality. The New England journal of medicine. 2013 Nov 21;369(21):2001–11.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Erickson N, Wawer A. Prinzipien der mediterranen Ernährung: Definition, Hintergrund, Eigenschaften und klinische Bedeutung. Aktuel Ernahrungsmed. 2015 // 17.12.2015;40(06):355–9.Google Scholar
  60. 60.
    Estruch R, Ros E, Salas-Salvado J, Covas MI, Corella D, Aros F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. The New England journal of medicine. 2013 Apr 4;368(14):1279–90.CrossRefPubMedGoogle Scholar
  61. 61.
    Wang X, Ouyang Y, Liu J, Zhu M, Zhao G, Bao W, et al. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ (Clinical research ed). 2014;349:g4490.Google Scholar
  62. 62.
    Endo J, Arita M. Cardioprotective mechanism of omega-3 polyunsaturated fatty acids. Journal of cardiology. 2016 Jan;67(1):22–7.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Medizin 2016

Authors and Affiliations

  1. 1.Klinikum der Universität München Medizinische Klinik und Poliklinik II — GroßhadernMünchenDeutschland

Personalised recommendations